Hence, the primary aim of our study is to comprehensively evaluate the clinical manifestations, therapeutic outcomes and molecular profiles of advanced EGFR-positive nonsquamous lung cancer patients within our tertiary care setting in Pakistan. The gene discussed is EGFR; the disease is lung cancer.